Fount Bio
PrivateLast Round
Series A
Feb 28, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Fount Bio is a life sciences company that develops innovative, glycopolymer-based products for medical aesthetics and consumer beauty applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fount Bio Comparables
Compare Fount Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eirion Therapeutics | 78% | |
| Innoture | 67% | |
| Teoxane Laboratories | 66% |
Fount Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 28, 2022 |
Fount Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 32% month-over-month.
- Apr 17, 2026
Monthly visitors grew 6400% MoM, from 18 to 1.2K.
Fount Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fount Bio's valuation, stock price, and market status.
Is Fount Bio a public or private company?
Fount Bio is a private company.
What is the current stock price of Fount Bio?
Fount Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Fount Bio worth (valuation)?
Valuation information for Fount Bio is not publicly available.
Can I buy Fount Bio stock?
Fount Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Fount Bio's last funding round?
Fount Bio's most recent funding round was Series A on February 28, 2022.
Who are the main investors in Fount Bio?
Key investors in Fount Bio include Morningside Ventures.
Will Fount Bio IPO soon?
No public IPO plans have been announced for Fount Bio.
How can I track Fount Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fount Bio's secondary market activity and sign up for updates.